IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Windlas Biotech

NSE:WINDLAS · ISIN INE0H5O01029

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Windlas Biotech

Ratings & risks

Credit signals

Rating-action history

Agency evidence
ICRA Limited · Windlas Biotech Limited: Long-term rating reaffirmed, short term rating upgraded to [ICRA]A1+, rated amount enhancedICRA Limited · PDF preserved by IndiaTicker
Archived PDF
ICRA Limited · Windlas Biotech Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Windlas Biotech Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Windlas Biotech Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Windlas Biotech Limited: Long-term rating upgraded to [ICRA]A+(Stable); Short-term rating reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Windlas Biotech Private Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Windlas Biotech Private Limited: Update on Material EventICRA Limited · discovered
Agency source
ICRA Limited · Windlas Biotech Private Limited: Ratings of [ICRA]A (Stable)/[ICRA]A1 reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Windlas Biotech Private Limited: Ratings upgraded to [ICRA]A(Stable)/A1ICRA Limited · discovered
Agency source
ICRA Limited · Ratings Reaffirmed at [ICRA]A-/[ICRA]A2+ for bank facilities of Windlas Biotech Private Limited, Outlook revised to ‘Positive’ICRA Limited · discovered
Agency source
Risk research framework

Questions to test against evidence

Analyst review
Operating deterioration

Track sector-specific operating metrics and reconcile them across reporting periods.

High
Funding and liquidity

Review debt maturity, repricing, liquidity and rating commentary where relevant.

High
Execution versus guidance

Compare management statements with subsequent reported delivery.

Medium
Governance and key-person change

Connect management transitions, related parties and auditor observations.

Medium